Kirchhoff LV, 1995. Trypanosoma species (American Tryponosomiasis, Chagas Disease): biology of trypanosomes. Mandell GL, Douglas RG, Bennett JE, eds. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 2442–2450.
Prata A, 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1 :92–100.
Dumonteil E, 1999. Update on Chagas’ disease in Mexico. Salud Publica Mex 41 :322–327.
Dias JC, Silveira AC, Schofield CJ, 2002. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 97 :603–612.
Becerril-Flores MA, Rangel-Flores E, Imbert-Palafox JL, Gomez-Gomez JV, Figueroa-Gutierrez AH, 2007. Human infection and risk of transmission of Chagas disease in Hidalgo State, Mexico. Am J Trop Med Hyg 76 :318–323.
Cruz-Reyes A, Pickering-Lopez JM, 2006. Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years—a review. Mem Inst Oswaldo Cruz 101 :345–354.
Ramsey JM, Cruz-Celis A, Salgado L, Espinosa L, Ordonez R, Lopez R, Schofield CJ, 2003. Efficacy of pyrethroid insecticides against domestic and peridomestic populations of Triatoma pallidipennis and Triatoma barberi (Reduviidae:Triatominae) vectors of Chagas’ disease in Mexico. J Med Entomol 40 :912–920.
Motran CC, Serra HM, Gea SE, Vullo CM, Vottero-Cima E, 1994. Antibody isotypes profiles against Trypanosoma cruzi acidic antigens in two Amerindian populations from a Chagas’ disease endemic area. Acta Trop 58 :105–114.
Rojas de Arias A, de Guillen I, Inchausti A, Samudio M, Schmeda-Hirschmann G, 1993. Prevalence of Chagas’ disease in Ayoreo communities of the Paraguayan Chaco. Trop Med Parasitol 44 :285–288.
Avila A, Barthas B, Cervantes A, 1995. Los Huastecos de San Luis Potosi. Etnografia Contemporanea de los Pueblos Indigenas de Mexico. Region Oriental. Mexico: Instituto Nacional Indigenista, Mexico, DF, Mexico: Secretaria de Desarrollo Social.
Garcia-Ortiz L, Vargas-Alarcon G, Fragoso JM, Granados J, Maldonado Noriega L, Navas Perez A, Huerta Reyes E, Zenteno-Ruiz JC, Martinez-Cordero E, 2008. A/G Gln20Arg (exon 1) and G/A Val156Met (exon 5) polymorphisms of the human orosomucoid 1 gene in Mexico. Genet Mol Res 7 :7–15.
Vargas-Alarcon G, Hernandez-Pacheco G, Zuniga J, Rodriguez-Perez JM, Perez-Hernandez N, Rangel C, Villarreal-Garza C, Martinez-Laso J, Granados J, Arnaiz-Villena A, 2003. Distribution of HLA-B alleles in Mexican Amerindian populations. Immunogenetics 54 :756–760.
Vargas-Alarcon G, Hernandez-Pacheco G, Moscoso J, Perez-Hernandez N, Murguia LE, Moreno A, Serrano-Vela JI, Granados J, Arnaiz-Villena A, 2006. HLA genes in Mexican Teeneks: HLA genetic relationship with other worldwide populations. Mol Immunol 43 :790–799.
Enger KS, Ordonez R, Wilson ML, Ramsey JM, 2004. Evaluation of risk factors for rural infestation by Triatoma pallidipennis (Hemiptera: Triatominae), a Mexican vector of Chagas disease. J Med Entomol 41 :760–767.
Estrada-Franco JG, Bhatia V, Diaz-Albiter H, Ochoa-Garcia L, Barbabosa A, Vazquez-Chagoyan JC, Martinez-Perez MA, Guzman-Bracho C, Garg N, 2006. Human Trypanosoma cruzi infection and seropositivity in dogs, Mexico. Emerg Infect Dis 12 :624–630.
World Health Organization, 1991. Control of Chagas Disease. Geneva: World Health Organization.
Guzman-Bracho C, 2001. Epidemiology of Chagas disease in Mexico: an update. Trends Parasitol 17 :372–376.
Sanchez-Guillen Mdel C, Lopez-Colombo A, Ordonez-Toquero G, Gomez-Albino I, Ramos-Jimenez J, Torres-Rasgado E, Salgado-Rosas H, Romero-Diaz M, Pulido-Perez P, Perez-Fuentes R, 2006. Clinical forms of Trypanosoma cruzi infected individuals in the chronic phase of Chagas disease in Puebla, Mexico. Mem Inst Oswaldo Cruz 101 :733–740.
Sosa-Jurado F, Mazariego-Aranda M, Hernandez-Becerril N, Garza-Murillo V, Cardenas M, Reyes PA, Hirayama K, Monteon VM, 2003. Electrocardiographic findings in Mexican chagasic subjects living in high and low endemic regions of Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 98 :605–610.
Wastavino GR, Cabrera-Bravo M, Garcia De La Torre G, Vences-Blanco M, Hernandez AR, Torres MB, Gomez YG, Mesa A, Schettino PM, 2004. Insecticide and community interventions to control Triatoma dimidiata in localities of the State of Veracruz, Mexico. Mem Inst Oswaldo Cruz 99 :433–437.
Olivera-Mar A, Hernandez-Vicencio C, Camacho-Marie M, Hernandez-Becerril N, Monteon-Padilla VM, Vallejo M, Reyes PA, 2006. [Chronic Chagasic cardiomyopathy at the Hospital General de Zona no. 24 IMSS. Poza Rica, Veracruz]. Arch Cardiol Mex 76 :269–276.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 54 | 37 | 5 |
Full Text Views | 495 | 2 | 0 |
PDF Downloads | 36 | 2 | 0 |
Scarce information on the seroprevalence of Trypanosoma cruzi among Amerindians is available, and the distribution of this disease in Mexican Indian populations is unknown. In this study, the presence of specific antibodies against T. cruzi among Teenek Amerindians in nine different communities located in San Luis Potosi State was analyzed. An average seroprevalence of 6.5% was found in these populations, suggesting that active transmission of disease occurs in this relatively isolated population in Mexico, and therefore, further studies should be conducted to identify risk factor associated to Chagas disease in other isolated populations across the country to determine the prevalence of Chagas disease in Mexican Amerindians.
Kirchhoff LV, 1995. Trypanosoma species (American Tryponosomiasis, Chagas Disease): biology of trypanosomes. Mandell GL, Douglas RG, Bennett JE, eds. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 2442–2450.
Prata A, 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1 :92–100.
Dumonteil E, 1999. Update on Chagas’ disease in Mexico. Salud Publica Mex 41 :322–327.
Dias JC, Silveira AC, Schofield CJ, 2002. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 97 :603–612.
Becerril-Flores MA, Rangel-Flores E, Imbert-Palafox JL, Gomez-Gomez JV, Figueroa-Gutierrez AH, 2007. Human infection and risk of transmission of Chagas disease in Hidalgo State, Mexico. Am J Trop Med Hyg 76 :318–323.
Cruz-Reyes A, Pickering-Lopez JM, 2006. Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years—a review. Mem Inst Oswaldo Cruz 101 :345–354.
Ramsey JM, Cruz-Celis A, Salgado L, Espinosa L, Ordonez R, Lopez R, Schofield CJ, 2003. Efficacy of pyrethroid insecticides against domestic and peridomestic populations of Triatoma pallidipennis and Triatoma barberi (Reduviidae:Triatominae) vectors of Chagas’ disease in Mexico. J Med Entomol 40 :912–920.
Motran CC, Serra HM, Gea SE, Vullo CM, Vottero-Cima E, 1994. Antibody isotypes profiles against Trypanosoma cruzi acidic antigens in two Amerindian populations from a Chagas’ disease endemic area. Acta Trop 58 :105–114.
Rojas de Arias A, de Guillen I, Inchausti A, Samudio M, Schmeda-Hirschmann G, 1993. Prevalence of Chagas’ disease in Ayoreo communities of the Paraguayan Chaco. Trop Med Parasitol 44 :285–288.
Avila A, Barthas B, Cervantes A, 1995. Los Huastecos de San Luis Potosi. Etnografia Contemporanea de los Pueblos Indigenas de Mexico. Region Oriental. Mexico: Instituto Nacional Indigenista, Mexico, DF, Mexico: Secretaria de Desarrollo Social.
Garcia-Ortiz L, Vargas-Alarcon G, Fragoso JM, Granados J, Maldonado Noriega L, Navas Perez A, Huerta Reyes E, Zenteno-Ruiz JC, Martinez-Cordero E, 2008. A/G Gln20Arg (exon 1) and G/A Val156Met (exon 5) polymorphisms of the human orosomucoid 1 gene in Mexico. Genet Mol Res 7 :7–15.
Vargas-Alarcon G, Hernandez-Pacheco G, Zuniga J, Rodriguez-Perez JM, Perez-Hernandez N, Rangel C, Villarreal-Garza C, Martinez-Laso J, Granados J, Arnaiz-Villena A, 2003. Distribution of HLA-B alleles in Mexican Amerindian populations. Immunogenetics 54 :756–760.
Vargas-Alarcon G, Hernandez-Pacheco G, Moscoso J, Perez-Hernandez N, Murguia LE, Moreno A, Serrano-Vela JI, Granados J, Arnaiz-Villena A, 2006. HLA genes in Mexican Teeneks: HLA genetic relationship with other worldwide populations. Mol Immunol 43 :790–799.
Enger KS, Ordonez R, Wilson ML, Ramsey JM, 2004. Evaluation of risk factors for rural infestation by Triatoma pallidipennis (Hemiptera: Triatominae), a Mexican vector of Chagas disease. J Med Entomol 41 :760–767.
Estrada-Franco JG, Bhatia V, Diaz-Albiter H, Ochoa-Garcia L, Barbabosa A, Vazquez-Chagoyan JC, Martinez-Perez MA, Guzman-Bracho C, Garg N, 2006. Human Trypanosoma cruzi infection and seropositivity in dogs, Mexico. Emerg Infect Dis 12 :624–630.
World Health Organization, 1991. Control of Chagas Disease. Geneva: World Health Organization.
Guzman-Bracho C, 2001. Epidemiology of Chagas disease in Mexico: an update. Trends Parasitol 17 :372–376.
Sanchez-Guillen Mdel C, Lopez-Colombo A, Ordonez-Toquero G, Gomez-Albino I, Ramos-Jimenez J, Torres-Rasgado E, Salgado-Rosas H, Romero-Diaz M, Pulido-Perez P, Perez-Fuentes R, 2006. Clinical forms of Trypanosoma cruzi infected individuals in the chronic phase of Chagas disease in Puebla, Mexico. Mem Inst Oswaldo Cruz 101 :733–740.
Sosa-Jurado F, Mazariego-Aranda M, Hernandez-Becerril N, Garza-Murillo V, Cardenas M, Reyes PA, Hirayama K, Monteon VM, 2003. Electrocardiographic findings in Mexican chagasic subjects living in high and low endemic regions of Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 98 :605–610.
Wastavino GR, Cabrera-Bravo M, Garcia De La Torre G, Vences-Blanco M, Hernandez AR, Torres MB, Gomez YG, Mesa A, Schettino PM, 2004. Insecticide and community interventions to control Triatoma dimidiata in localities of the State of Veracruz, Mexico. Mem Inst Oswaldo Cruz 99 :433–437.
Olivera-Mar A, Hernandez-Vicencio C, Camacho-Marie M, Hernandez-Becerril N, Monteon-Padilla VM, Vallejo M, Reyes PA, 2006. [Chronic Chagasic cardiomyopathy at the Hospital General de Zona no. 24 IMSS. Poza Rica, Veracruz]. Arch Cardiol Mex 76 :269–276.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 54 | 37 | 5 |
Full Text Views | 495 | 2 | 0 |
PDF Downloads | 36 | 2 | 0 |